If you find this podcast useful please give it a rating and review on iTunes by clicking here
On today's Vox Markets Podcast: Avacta: Paul Hill discusses the Clinical validation of their AffiDX Lateral Flow Test & Glen Goodman on Crypto
Paul Hill discusses the Clinical validation of Avacta's #AVCT AffiDX Lateral Flow Test which shows 100% clinical sensitivity for samples with PCR Ct values up to 27.
Avacta Group is developing powerful diagnostics and novel cancer immunotherapies based on its two proprietary platforms - Affimer® biologics and pre|CISION™ tumour targeted chemotherapies.
Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", covers this week’s Bitcoin, Blockchain and Cryptocurrency news. Crypto's mentioned include: $BTC $DODG $ETH $NMR $ALGO $ANKR $NKN $ENJ $NU $OXT #DNT
(Interview starts 14 minutes 38 seconds)